Amarin Corporation plc (AMRN) Cash on Hand per Share

Amarin Corporation plc is integrating sustainability and bioethics principles into the production of cardiovascular drugs. However, the expansion of affordable generics is undermining revenue, forcing the company to cut costs to survive. The distribution of cash per share visualizes this balance, where 15.34 represents the current metric level, capturing liquidity dynamics under conditions of strict resource austerity.
Comprehensive metric breakdowns and analytics for Amarin Corporation (AMRN)

This indicator determines the share of net liquidity per security, allowing for an assessment of the asset's intrinsic protection relative to its market value. By analyzing the cash per share, an investor can discern the financial stability of Amarin Corporation plc (AMRN), where a significant cash reserve ensures business viability during cost restructuring and the commercialization of the drug Vascepa amid market volatility.